Mindfulness

, Volume 3, Issue 4, pp 318–326 | Cite as

Employee’s Preferences for Access to Mindfulness-Based Cognitive Therapy to Reduce the Risk of Depressive Relapse—A Discrete Choice Experiment

  • Mark A. Lau
  • Lindsey Colley
  • Brandilyn R. Willett
  • Larry D. Lynd
ORIGINAL PAPER

Abstract

Disseminating mindfulness-based cognitive therapy (MBCT), an evidence-based group treatment, in the workplace may help employees who have recovered from depression to prevent depressive relapse and stay well. Employees’ potential confidentiality concerns about participating in a group-based workplace MBCT intervention may be alleviated by delivering MBCT in alternative formats that would maintain the employees’ anonymity. The aim of the current study was to determine the stated preferences of employees from large healthcare organizations for four different MBCT delivery methods (i.e., group, online group, individual, and individual via the telephone). We determined the stated preferences of 151 health authority employees for the four MBCT delivery methods using a discrete choice experiment comprised of 18 choice sets of five attributes. A latent class model was used to evaluate the heterogeneity of respondents' preferences. This analysis suggested that four classes existed in the sample. The most important preferences were the effectiveness of MBCT, the type of interaction, face-to-face delivery, and receipt of MBCT on their own time. These results suggest strong preferences for the four different MBCT delivery methods. The presence of latent classes also shows that preferences for alternative modes of delivery vary in association with differences in sociodemographic variables between groups of employees. The overall findings of this study have the potential to influence the development of institutional programs that could make workplace MBCT more appealing to a greater number of employees, thereby improving participant uptake, decreasing the potential for depressive relapse, and minimizing absenteeism.

Keywords

Mindfulness-based cognitive therapy Depression Stated preferences Discrete choice experiment 

References

  1. American Psychological Association. (2010). Ethical principles of psychologists and code of conduct. Washington, DC. http://www.apa.org/ethics/code/index.aspx. Accessed: 19 June 2011.
  2. Attridge, M. (2008). A quiet crisis: the business case for managing employee mental health—human solutions report. Wilson Banwell PROACT Human Solutions. Google Scholar
  3. Australian Psychological Society. (2011). Code of ethics. Melbourne: Australian Psychological Society.Google Scholar
  4. Berti Ceroni, G., Neri, C., & Pezzoli, A. (1984). Chronicity in major depression. A naturalistic perspective. Journal of Affective Disorders, 7(2), 123–132.PubMedCrossRefGoogle Scholar
  5. Chang, S. M., Hong, J. P., & Cho, M. J. (2011). Economic burden of depression in South Korea. Social Psychiatry and Psychiatric Epidemiology. doi:10.1007/s00127-011-0382-8.
  6. Coelho, H. F., Canter, P. H., & Ernst, E. (2007). Mindfulness-based cognitive therapy: evaluating current evidence and informing future research. Journal of Consulting and Clinical Psychology, 75, 1000–1005.PubMedCrossRefGoogle Scholar
  7. Cooper, C., Bebbington, P., King, M., Brugha, T., Meltzer, H., Bhugra, D., et al. (2007). Why people do not take their psychotropic drugs as prescribed: results of the 2000 National Psychiatric Morbidity Survey. Acta Psychiatrica Scandinavica, 116, 47–53.PubMedCrossRefGoogle Scholar
  8. Dewa, C. C., Lesage, A., Goering, P., & Caveen, M. (2004). Nature and prevalence of mental illness in the workplace. Healthcare Papers, 5, 12–25.PubMedGoogle Scholar
  9. Farrar, S., Ryan, M., Ross, D., & Ludbrook, A. (2000). Using discrete choice modelling in priority setting: an application to clinical service developments. Social Science & Medicine, 50(1), 63–75.CrossRefGoogle Scholar
  10. Greenberg, P. E., Kessler, R. C., Birnbaum, H. G., Leong, S. A., Lowe, S. W., Berglund, P. A., et al. (2003). The economic burden of depression in the United States: how did it change between 1990 and 2000? The Journal of Clinical Psychiatry, 64, 1465–1475.PubMedCrossRefGoogle Scholar
  11. Guimaraes, C., Marra, C. A., Colley, L., Gill, S., Simpson, S. H., Meneilly, G. S., et al. (2009). A valuation of patients' willingness-to-pay for insulin delivery in diabetes. International Journal of Technology Assessment in Health Care, 25(3), 359–66.PubMedCrossRefGoogle Scholar
  12. Guimaraes, C., Marra, C. A., Gill, S., Simpson, S., Meneilly, G., Queiroz, R. H., et al. (2011). A discrete choice experiment evaluation of patients' preferences for different risk, benefit, and delivery attributes of insulin therapy for diabetes management. Patient Preference and Adherence, 4, 433–40.Google Scholar
  13. Healthcare Benefit Trust. (2007). Provincial Health Services Authority report on employee workplace health survey. Vancouver: Author.Google Scholar
  14. Hole, A. R. (2008). Modelling heterogeneity in patients' preferences for the attributes of a general practitioner appointment. Journal of Health Economics, 27(4), 1078–94.PubMedCrossRefGoogle Scholar
  15. Ipsos Reid. (2007). Mental health in the workplace: Largest study ever conducted of Canadian workplace mental health and depression. http://www.ipsos-na.com/news-polls/pressrelease.aspx?id=3724. Accessed: 13 June 2011.
  16. Judd, L. J. (1997). The clinical course of unipolar major depressive disorders. Archives of General Psychiatry, 54, 989–991.PubMedCrossRefGoogle Scholar
  17. Keller, M. B., Lavori, P. W., Lewis, C. E., & Klerman, G. L. (1983). Predictors of relapse in major depressive disorder. Journal of the American Medical Association, 250(24), 3299–3304.PubMedCrossRefGoogle Scholar
  18. Kessler, R. C., Kessler, R. C., Akiskal, H. S., Ames, M., et al. (2006). Prevalence and effects of mood disorders on work performance in a nationally representative sample of U.S. workers. American Journal of Psychiatry, 163, 1561–1568.PubMedCrossRefGoogle Scholar
  19. Kuyken, W., Byford, S., Taylor, R. S., Watkins, E., Holden, E., White, K., et al. (2008). Mindfulness-based cognitive therapy to prevent relapse in recurrent depression. Journal of Consulting and Clinical Psychology, 76(6), 966–978.PubMedCrossRefGoogle Scholar
  20. Kwan, B. M., Dimidjian, S., & Rizvi, S. L. (2010). Treatment preference, engagement, and clinical improvement in pharmacotherapy versus psychotherapy for depression. Behavioral Research Therapy, 48, 799–804. doi:10.1016/j.brat.2010.04.003.CrossRefGoogle Scholar
  21. Lancsar, E., & Louvier, J. (2006). Deleting irrational responses from discrete choice experiments: a case of investigating or imposing preferences? Journal of Health Economics, 18, 797–812.Google Scholar
  22. Lang, A. J. (2005). Mental health treatment preferences of primary care patients. Journal of Behavioral Medicine, 28, 581–586. doi:10.1007/s10865-005-9019-2.PubMedCrossRefGoogle Scholar
  23. Lau, M. A., Grabovac, A., & Willett, B. (2010). Mindfulness-based cognitive therapy for the prevention of depressive relapse in the workplace. Paper presented as part of a symposium entitled “Mental Health in the Workplace: An Initiative of the Great West Life Innovation Fund of the FCPA” at the 60th Canadian Psychiatric Association Annual Conference, Toronto, Canada.Google Scholar
  24. Ma, S. H., & Teasdale, J. D. (2004). Mindfulness-based cognitive therapy for depression: replication and exploration of differential relapse prevention effects. Journal of Consulting and Clinical Psychology, 72, 31–40.PubMedCrossRefGoogle Scholar
  25. Marcotte, E. M., Pellegrini, M., & Thompson, M. J. (1999). A combined algorithm for genome-wide prediction of protein function. Nature, 402, 83–86.PubMedCrossRefGoogle Scholar
  26. Mark, T. L., & Swait, J. (2004). Using stated preference and revealed preference modeling to evaluate prescribing decisions. Health Economics, 13(6), 563–73.PubMedCrossRefGoogle Scholar
  27. McFadden, D., & Train, L. (2000). Mixed MNL models for discrete response. Journal of Applied Econometrics, 15, 447–70.CrossRefGoogle Scholar
  28. McTaggart-Cowan, H. M., Shi, P., Fitzgerald, J. M., Anis, A. H., Kopec, J., Bai, T., et al. (2008). An evaluation of patients' willingness to trade off symptom-free days for asthma-related treatment risks: a discrete choice experiment. The Journal of Asthma, 45, 630–38.PubMedCrossRefGoogle Scholar
  29. Murphy, J. M., Laird, N. M., Monson, R. R., Sobol, A. M., & Leighton, A. H. (2000). Incidence of depression in the Stiling County Study: historical and comparative perspectives. Psychological Medicine, 30(3), 505–514.PubMedCrossRefGoogle Scholar
  30. National Health Services. (2011). About NHS: NHS core principles. http://www.nhs.uk/NHSEngland/thenhs/about/Pages/nhscoreprinciples.aspx. Accessed: 21 June 2011.
  31. National Institute for Clinical Excellence (NICE). (2009). Management of depression in primary and secondary care. London: National Institute for Clinical Excellence.Google Scholar
  32. Newman, S. C., & Bland, R. C. (1998). Incidence of mental disorders in Edmonton: estimates of rates and methodological issues. Journal of Psychiatric Research, 32(5), 273–282.PubMedCrossRefGoogle Scholar
  33. Offord, D. R., Boyle, M. H., Campbell, D., Goering, P., Lin, E., Wong, M., et al. (1996). One year prevalence of psychiatric disorder in Ontarians 15 to 64 years of age. Canadian Journal of Psychiatry, 41, 559–563.Google Scholar
  34. Oteng, B., Marra, F., Lynd, L. D., Ogilvie, G., Patrick, D., & Marra, C. A. (2010). Evaluating societal preferences for human papillomavirus vaccine and cervical smear test screening programme. Sexually Transmitted Infections, 87(1), 52–7.PubMedCrossRefGoogle Scholar
  35. Patten, S. B., Wang, J. L., Williams, J. V. A., Currie, S., Beck, C. A., Maxwell, C. J., et al. (2006). Descriptive epidemiology of major depression in Canada. Canadian Journal of Psychiatry, 51(5), 84–90.Google Scholar
  36. Ryan, M., & Gerard, K. (2003). Using discrete choice experiments to value health care programmes: current practice and future research reflections. Applied Health Economics and Health Policy, 2(1), 55–64.PubMedGoogle Scholar
  37. Segal, Z. V., Williams, J. M. G., & Teasdale, J. D. (2002). Mindfulness-based cognitive therapy for depression: a new approach for preventing relapse. New York: Guilford Press.Google Scholar
  38. Segal, Z. V., Bieling, P., Young, T., MacQueen, G., Cooke, R., Lawrence, M., et al. (2010). Antidepressant monotherapy vs sequential pharmacotherapy and mindfulness-based cognitive therapy, or placebo, for relapse prophylaxis in recurrent depression. Archives of General Psychiatry, 67(12), 1256–1264.PubMedCrossRefGoogle Scholar
  39. Sobocki, P., Jonsson, B., Angst, J., & Rehnberg, C. (2006). Cost of depression in Europe. The Journal of Mental Health Policy and Economics, 9, 87–98.PubMedGoogle Scholar
  40. Swift, J. K., & Callahan, J. L. (2009). The impact of client treatment preferences on outcome: a meta-analysis. Journal of Clinical Psychology, 65, 368–381. doi:10.1002/jclp.20553.PubMedCrossRefGoogle Scholar
  41. Swift, J. K., Callahan, J. L., & Vollmer, B. M. (2011). Preferences. Journal of Clinical Psychology, 67, 155–165. doi:10.1002/jclp.20759.PubMedCrossRefGoogle Scholar
  42. Teasdale, J. D., Segal, Z. V., Williams, J. M. G., Ridgeway, V. A., Soulsby, J. M., & Lau, M. A. (2000). Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. Journal of Consulting and Clinical Psychology, 68, 615–623.PubMedCrossRefGoogle Scholar
  43. Telser, H., & Zweifel, P. (2002). Measuring willingness-to-pay for risk reduction: an application of conjoint analysis. Health Economics, 11, 129–139.PubMedCrossRefGoogle Scholar
  44. Wang, P. S., Beck, A. L., Berglund, P., McKenas, D. K., Pronk, N. P., Simon, G. E., et al. (2004). Effects of major depression on moment-in-time work performance. The American Journal of Psychiatry, 161, 1885–1891.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  • Mark A. Lau
    • 3
  • Lindsey Colley
    • 1
    • 2
  • Brandilyn R. Willett
    • 3
  • Larry D. Lynd
    • 1
    • 2
  1. 1.Faculty of Pharmaceutical SciencesUniversity of British ColumbiaVancouverCanada
  2. 2.Centre for Health Evaluation and Outcome SciencesVancouverCanada
  3. 3.BC Mental Health and Addiction Services, Department of PsychiatryUniversity of British ColumbiaVancouverCanada

Personalised recommendations